Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Mehdi Manoochehri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2097-2558; OpenAlex author ID A5069260089. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Individualized neoantigen peptide immunization of a metastatic pancreatic cancer patient: a case report of combined tumor and liquid biopsy. Co-author DOI 10.3389/fimmu.2024.1414737↗
  2. DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma. Co-author DOI 10.1136/gutjnl-2023-330155↗
  3. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis. Co-author DOI 10.1002/1878-0261.12684↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nathalia A. Giese · 2 shared papers, 2020–2023 · strength 0.27
  2. Thilo Hackert · 2 shared papers, 2020–2023 · strength 0.27
  3. Andrea S. Bauer · 2 shared papers, 2020–2023 · strength 0.27
  4. Yenan Wu · 2 shared papers, 2020–2023 · strength 0.27
  5. Jörg D. Hoheisel · 2 shared papers, 2020–2023 · strength 0.27
  6. Tim Röhnisch · 1 shared paper, 2024 · strength 0.22
  7. Wolfgang Schönharting · 1 shared paper, 2024 · strength 0.22
  8. Markus Wolfgang Büchler · 1 shared paper, 2023 · strength 0.16
  9. Fawaz N. Al-Shaheri · 1 shared paper, 2023 · strength 0.16
  10. Oliver Strobel · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.